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Greetings to everyone! I hope that you are well and healthy.  The year 2020 has been 
challenging so far due to the COVID-19 pandemic.  The pandemic has affected the 
world in all aspects, including social, economic, cultural and health aspects.  The 
situation in Malaysia is now under control, thanks to the prompt actions taken by 
the government authorities and relentless efforts by all frontliners, including our 
healthcare workers at the University of Malaya Medical Centre.
The containment of COVID-19 would not have been possible without the cooperation 
of the public, especially in maintaining personal hygiene and social distancing.  The 
cover photo in this issue is a perfect illustration of the importance of social distancing 
in mitigating the transmission of SARS-CoV-2 in the community.  The row of matches 
is symbolic of people in close social distance, and the burning matches are the affected 
individuals.  By removing a match from the line, the matches beyond it are saved from 
being scorched.  This simple visual concept reminds everyone that self-isolation and 
social distancing are both an individual and societal responsibility. 
While the world is working tirelessly to combat the COVID-19 pandemic, researchers 
from the Faculty of Medicine initiated several impactful Covid-related projects.  In this 
issue, the cover stories include UMMC’s initiative on using surveillance information to 
monitor and protect healthcare workers in the hospital; research on the evolutionary 
relationship of SARS-CoV-2 and animal coronaviruses; and one of the first Covid 
clinical trials in Malaysia on the use of Tocilizumab against severe COVID-19 cases 
started in UMMC. Under a special section in this issue, we also feature exciting 
COVID-19 innovations designed by our Faculty researchers: the COVID-19 Symptom 
Monitoring System (CoSMoS), bibliometric database for COVID-19 publications, and 
the complete genome sequencing of Malaysian SARS-CoV-2 strains.
There’s also some good news to celebrate amidst the Covid pandemic. A team of 
Faculty members has won a bronze medal at the Teaching and Learning Congress 
and Innovation Competition (kNovasi) 2020 for developing an innovative guide for 
problem-based learning in medical education.  The Faculty of Medicine now offers 
the Master of Health Research Ethics (MOHRE) programme, which aims to groom 
future leaders in research ethics to handle the increasingly complex ethical issues in 
biomedical research.  In March, a cancer research forum was organized to bridge 
cross-disciplinary research between clinical and pre-clinical researchers.  In addition, 
a community engagement project funded by UMCares was also conducted to cultivate 
science in secondary schools with fun and interactive modules.  
I hope you will enjoy reading this issue as much as I do. Stay safe!
Professor Dr. Ng Chirk Jenn
Pulse@UM editorial team : Adapting to the new norm
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COVID-19 Pandemic: Protecting 
the Health Care Worker using 
Surveillance Information
RAFDZAH AHMAD ZAKI
(Department of Social and Preventive Medicine)
to protect the HCWs by setting up the 
UMMC COVID-19 HCW Surveillance 
System. Surveillance of healthcare-
associated infections is one of the World 
Health Organization (WHO)’s eight 
core components of infection prevention 
and control.  While surveillance is a 
critical component of providing safe 
healthcare, it is important to recognize 
that it requires expertise, good quality 
data, and an established infection 
prevention and control program.
Health facility surveillance capacity varies 
within health systems. At this moment, the 
UMMC HCW surveillance system functions 
under medium capacity (according to the 
CDC guideline) with a standardized data 
collection, and some limitations in staff and 
data availability. The UMMC COVID-19 
Health Care workers surveillance operation 
room was first located in the Department 
of Social & Preventive Medicine (SPM) and 
was operated by the public health medicine 
specialists and nurses in that Department. 
Starting from 1st April 2020, the operation 
room has expanded its function and has 
moved to level 2 of the RUKA Building, 
UMMC. The role of the operation 
room includes rapid identification, risk 
assessment and management, follow-
up, and close monitoring of HCWs 
in contact with COVID-19 patients.
All UMMC staff who were exposed to 
COVID-19 patients will have their risk 
assessed and those with low, medium and 
high risk will be enrolled in the surveillance 
system. The particular staff will then be 
considered as persons under surveillance 
(PUS). Each PUS needs to report the 
absence or presence of COVID-19 
symptoms in him or her every day for 14 
days from the last date of exposure to a 
COVID-19 patient. A staff member who 
fails to report his or her symptoms will 
be followed up. This is consistent with the 
remote active strategy in surveillance to 
identify HCWs with suspected COVID-19. 
A guideline and decision algorithms for 
the response to HCW reports have been 
developed to ensure rapid and appropriate 
management of PUS. Early detection will 
result in a better disease outcome and 
prevent further spread of the infection. 
In addition, PUS also will be linked to 
psychological support to reduce their stress 
and anxiety during this pandemic period.
Information from the surveillance systems is 
compiled and analyzed to provide scientific 
and factual database essential for informed 
decision making and appropriate actions 
to improve the management of COVID-19 
patients and protect the HCWs. A simple 
analysis of basic information of HCWs 
such as job description, location of work, 
and type of personal protective equipment 
(PPE) used during the exposure, allows 
identification of the areas for improvement 
in reducing the risk of HCWs to COVID-19.
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Apart from the hazards 
of pathogen exposure, 
HCWs are also exposed 
to long working hours, 
psychological distress, fatigue, 
occupational burnout, 
stigma, and physical as well 
as psychological violence
“
“
Mreported its first COVID-19 case on the 25th of January 2020. Following 
this, the number of cases increased and 
a significant jump was observed in mid-
March. The number of new cases has 
stabilized and started to drop from the 
end of April. Within three months of the 
outbreak, Malaysia has reported a total of 
5,851 cases with 100 deaths (as of 28 April 
2020). 
The University of Malaya Medical Centre 
(UMMC) is one of the designated hospitals 
to screen and manage COVID-19 patients. 
Being a COVID-19 hospital, UMMC 
healthcare workers (HCWs) are exposed to 
hazards that put them at risk of COVID-19 
infection. Apart from the hazards of 
pathogen exposure, HCWs are also exposed 
to long working hours, psychological 
distress, fatigue, occupational burnout, 
social stigma, and physical as well as 
psychological violence. The Department of 
Public Health and the Occupational Safety 
Health and Environment (OSHE) unit in 
UMMC have put their efforts together
Continuous Evolution of 
SARS-CoV-2 and Animal 
Coronaviruses
TEE KOK KENG
(Department of Medical Microbiology)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which 
causes COVID-19, is a new virus that belongs 
to the family Coronaviridae that normally 
circulate in animals and humans. Like any 
other viruses, SARS-CoV-2 will continue 
to mutate while circulating in humans. 
Such mutations, however, are usually minor 
and take a long time to accumulate. In 
the past four months since the outbreak 
started, the virus has been spreading in 
many countries and genetic analysis of 
the virus sampled across the world has 
shown some degree of minor mutations, or 
polymorphisms, that are specific to certain 
geographical regions with epidemiological 
linkage. These mutations are most likely 
non-alarming, but serve as a “signature” 
that help epidemiologists to track the 
movement (gene flow) of the virus. So, 
not all mutations are harmful, per se. 
However, if certain mutations occur in 
some important proteins of the virus, 
either through a random event or positive 
selection, these mutations may change the 
phenotype or characteristics of the virus. 
Such mutants may cause more severe 
disease (increased virulence), greater 
transmissibility (increased virus fitness), 
more resistance to the human immune 
response (escape mutants), or simply 
non-detectability by the conventional 
diagnostic assay that was designed based 
on the wild type strain (diagnostic drift). 
However, such events are yet to be reported 
in the literature at this point. Therefore, 
continuous genetic surveillance and 
mass sequencing are essential to trace the 
distribution and dispersion of the virus.
In addition to genetic surveillance in the 
community, continuous search for other 
animal coronaviruses that may have the 
potential for cross-species transmission 
from the reservoir and/or intermediate 
host(s) to humans remains an important 
goal in understanding zoonotic diseases.
Active surveillance of HCWs can be highly 
resource-intensive. An automated method 
through mass texting service to contact 
HCWs as a prompt for self-assessment 
through the UMMC portal is now being 
developed. It is hoped this will help to 
improve the overall quality of the UMMC 
COVID-19 HCW Surveillance System and 
its sustainability.  Thus, UMMC HCWs can 
be continuously monitored and protected 
throughout this COVID-19 pandemic.
For more information on a series of news 
clips, articles and media interviews on 
COVID19, please visit https://spm.um.edu.
my/
References:
1. Operational Considerations for the 
Identification of Healthcare Workers and 
Inpatients with Suspected COVID-19 in non-
US Healthcare Settings. https://www.cdc.gov/
coronavirus/2019-ncov/hcp/non-us-settings/
guidance-identify-hcw-patients.html
2. Guidelines on core components of infection 
prevention and control programmes at the 
national and acute health care facility level. 
World Health Organization 2016. https://www.
who.int/gpsc/ipc-components/en/
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Like any other viruses, 
SARS-CoV-2 will continue to 
mutate while circulating in 
humans
“
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Surveillance team responsible for the monitoring of COVID-19 among healthcare workers in PPUM
The full genome of SARS-CoV-2 shares 
96.2% identity with betacoronaviruses 
identified in the Rhinolophus affinis bats in 
the Yunnan province in China, indicating 
the bat-origin of SARS-CoV-2. Rhinolophus 
spp. are abundant and diverse in Southern 
China and across Asia, the Middle East, 
Africa and Europe. Intriguingly, prior to the 
COVID-19 outbreak, more than 500 species 
of CoV have already been identified in bats 
in China, many of which do not cause any 
disease symptoms in their natural hosts. 
It has also been speculated that up to a 
staggering 5,000 previously unknown CoV 
species could be circulating insidiously 
in bats. However, the route of spillover 
from bats to humans remains unclear, and 
may involve domesticated mammals, and 
farmed or hunted wildlife. Tracking the 
(sero) prevalence, continuous evolution and 
movement of animal coronaviruses may help 
prevent the spillover of zoonotic viruses, 
limiting the potential of another pandemic.
COVID-19 Trial: Tocilizumab 
Against Cytokine Storm In 
Severe Cases
MALINEE NEELAMEGAM
(Department of Medicine)
Led by the Dean of University Malaya Faculty of Medicine, Professor Datuk 
Dr Adeeba Kamarulzaman, clinicians and 
researchers at University Malaya Medical 
Centre (UMMC), and three Ministry 
of Health Malaysia hospitals (Sungai 
Buloh Hospital, Kuala Lumpur Hospital 
and Tuanku Jaafar Hospital, Seremban) 
will be conducting a clinical trial to 
evaluate the efficacy of Tocilizumab for 
the treatment of severe cases of Covid-19.
In this randomized controlled clinical 
trial, investigators aim to compare the 
efficacy of intravenous Tocilizumab 
against Methylprednisolone, a high-
dose corticosteroid in approximately 
310 hospitalised, severely ill Covid-19 
patients. Tocilizumab is conventionally 
used for the treatment of rheumatoid 
arthritis and conditions of excessive 
inflammation. Patients in the study will be 
randomized to receive either Tocilizumab 
or Methylprednisolone, both of which 
are known to inhibit inflammation.
While approximately 80% of Covid-19 
patients have mild to moderate symptoms 
and eventually recover, 15% of infected 
individuals progress to severe Covid-19 
with another 5% developing critical illness 
due to the infection. Death is reported 
to be as high as 3% in Covid-19 patients.
As the pandemic progresses, clinicians 
are learning more about the underlying 
causes of progression to critical illness. In 
these individuals, a cytokine storm, or an 
uncontrolled release of cytokines by the 
immune system results in respiratory failure 
and the need for mechanical ventilation. 
A specific cytokine, interleukin-6 (IL-6) 
is a critical component of the Covid-19 
cytokine storm. Blocking IL-6 may stop 
the progression of the disease to its most 
critical stage. This is where investigators 
believe Tocilizumab, a drug specifically 
designed to block the negative effects of 
IL-6 can potentially reduce the severity 
of the illness. Covid-19 patients who 
develop the cytokine storm syndrome at 
UMMC have already shown encouraging 
results after receiving Tocilizumab.
The investigators strongly believe that this 
clinical trial has the potential to save many 
lives. It will move to contribute to the urgent 
need for evidence based effective treatment 
protocols for Covid-19 patients globally. 
REENA A/P RAJASURIAR
(Department of Medicine)
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COVID-19 Development and 
Innovation
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COVID-19 Top Cited Keywords Map
The Team
Just as the spread of the Covid-19 infection 
has been staggering, so has been the rate and 
spread of information about it. But people 
ask – what can be trusted? Now a multi-
disciplinary, multi-national team led by 
Prof Ng Kwan Hoong has developed a web-
based resource for accessing new research 
publications on Covid-19 using bibliometric 
measures (www.covid19bibliometrics.org).
It provides reliable information on what 
can be relied upon as sound science so that 
health professionals and scientists can guide 
research, find solutions, and help defeat this 
pandemic.
The team scans and analyses this constant 
output of knowledge and creates a regular 
series of overview charts providing a visual 
summary of the published literature. One 
example reveals five major clusters based 
on the frequency of keywords employed 
(see diagram above). One aim is to identify 
research trends and gaps in knowledge for 
future work.
Prof. Dr. Ng Kwan Hong
Team leader
Medical Physicist
Universiti Malaya
Assoc. Prof. Dr. Kiran Kaur
Information Scientist
Universiti Malaya
Assoc. Prof. Dr. Noorhidawati
Information Scientist
Universiti Malaya
Dr. Yanti Idayu Aspura
Information Scientist
Universiti Malaya
Dr. Anjanna Kukreja
Infectious Disease Specialist 
Universiti Malaya Medical 
Centre
Assoc. Prof. Dr. Yeong Chai 
Hong
Medical Physicist
Taylor’s University
Dr. Ray Kemp
Health Risk Communication 
Specialist
United Kingdom
The COVID-19 Symptom Monitoring System (CoSMoS) Study
COVID-19: Dynamic Knowledge Mapping
In response to the Covid-19 pandemic, 
members of the University of Malaya 
eHealth Initiative (UMeHI) - a collaborative 
research group that champions digital 
health research in UM – decided to 
develop CoSMoS to monitor patients with 
suspected Covid-19 infection, which is 
incurring a huge burden on the healthcare 
providers. Patients who agree to participate 
in the CoSMoS study will be monitored at 
home using an interactive Telegram bot 
and reminded to report their symptoms 
every day for 14 days. Patient data will then 
be sent to a centralised CoSMoS dashboard 
at the hospital, where doctors can monitor 
each patient’s condition in real-time and 
provide teleconsultation if necessary. 
The first CoSMoS prototype was developed 
within 8 days of project commencement 
while patients started using it within 2 
weeks after rigorous testing by the research 
team. This project is made possible by a 
strong multidisciplinary team comprising 
researchers, clinicians, students from 
Faculties of Medicine, Computer Science 
and Information Technology, and Law. 
Currently, the CoSMoS project is being 
carried out at the Primary Care Clinic 
(RUKA) and Emergency Department in 
UMMC. The preliminary feedback from 
both doctors and patients has been very 
encouraging, and there is a plan to expand 
CoSMoS to other healthcare settings 
to benefit more patients and healthcare 
providers. 
Lim Hooi Min, Department of Primary Care Medicine
RESEARCH SPOTLIGHT
Generating Solutions for 
Problem-Based Learning 
(PBL) Beginners
WONG KAH HUI
(Department of Anatomy)
FOONG CHAN CHOONG
(Faculty of Medicine Dean’s Office)
AMIRAH BINTI AMIR
(Department of Parasitology)
Problem-based learning, more commonly known as PBL, is a learning method in which students 
learn a subject by collaboratively solving 
an open-ended real world problem. Its 
nature of self-directed learning is in line 
with Malaysian Higher Education 4.0 
(MyHE 4.0) which focuses on learners as 
teachers/connection makers and educators 
as resource guides. Although PBL was first 
introduced in medical education more than 
five decades ago, it has only been 21 years 
since the University of Malaya adopted 
it into its medical curriculum. PBL in the 
University of Malaya medical curriculum 
started out as a hybrid traditional-PBL as 
a part of the New Integrated Curriculum 
(NIC), with just 14 PBL cases. Currently, 
there are 62 PBL cases conducted 
throughout the Year 1 and Year 2 studies 
within the new University of Malaya Medical 
Programme (UMMP). On average, medical 
students work on one PBL case weekly.
There are challenges in conducting PBL 
among novice medical students since they 
are usually untrained to collaboratively 
solve problems in secondary schools. 
Furthermore, some students may resent 
the idea of self-directed learning, especially 
since they might have been spoon-fed 
all their school life in an exam-oriented 
culture. Similarly, PBL tutors (i.e. lecturers) 
also need training. Tutors and students are 
trained before conducting their first PBL 
session, but it is usually during the actual PBL 
sessions where the challenges are practically 
seen. Dr. Wong Kah Hui, Dr. Foong Chan 
Choong and Dr. Amirah Amir were novice 
tutors who faced challenges in conducting 
PBL sessions among novice students. 
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PBL was introduced in 
medical education more 
than five decades ago
“
“
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Complete Genome Sequences of SARS-CoV-2 Strains Detected 
in Malaysia
Figures adapated from: Chong et al., 2020
A team of researchers led by Assoc. Prof. 
Dr. Chan Yoke Fun and Prof Jamal Sam 
sequenced four severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) 
genomes during the second wave of 
infection from Malaysia. It is the first 
publication that reported the full genome 
sequences of Malaysian SARS-CoV-2 
strains.  This is made possible by the team 
effort of the University Malaya COVID-19 
Research Group, which includes the 
healthcare workers involved in the care of 
COVID-19 patients in the University of 
Malaya Medical Centre.
Compared to reference strain Wuhan-Hu-1, 
the Malaysian sequences have 16 nucleotide 
substitutions. Four substitutions are unique 
to Malaysia, suggesting a degree of local 
evolution. Circulating Malaysian strains 
represent introductions from different 
countries, particularly during the first wave 
of infection. Our data showed that current 
circulating strains in Malaysia represent 
introductions from different countries and 
local evolution. More genomic data will 
clarify virus spread in Malaysia, particularly 
with respect to the role played by the mass 
gathering. Genome sequencing of virus has 
become a useful tool for epidemiological 
surveillance.
Article source: 
Chong YM, Sam I-C, Ponnampalavanar S, Syed Omar SF, 
Kamarulzaman A, Munusamy V, Wong CK, Jamaluddin 
FH, Gan HM, Chong J, Teh CSJ, Chan YF. 2020. Complete 
genome sequences of SARS-CoV-2 strains detected in 
Malaysia. Microbiol Resour Announc 9:e0038-20. https://
doi.org/10.1128/MRA.00383-20.
Chan Yoke Fun, Department of Medical Microbiology
(left to right) Dr. Foong Chan Choong, Dr. Wong Kah Hui, Dr Amirah Amir
TThey have gradually gained experience 
on how to overcome these challenges. 
They decided to write a guidebook ‘8 Top 
Tips to Facilitate Problem-Based Learning 
Among Novice Medical Students’ to share 
their actual experiences. The eight top tips 
are icebreaking, understanding roles and 
positions, ground rules, keeping discussion 
on the right track, dealing with different 
personalities and characters, teamwork, 
gathering valid information, and giving 
feedback. In the guidebook, each tip is 
elaborated using actual scenario(s), its 
possible solutions and corresponding 
rationales. For instance, some students 
might come late or may be engrossed in their 
smartphones. At the start of the PBL sessions, 
tutors should engage students to list rules 
that are achievable and deemed important. 
Every student has to agree to these rules. 
Examples of rules include being punctual, 
limiting smartphone usage and listening 
when someone is speaking. Since these rules 
are set by the student themselves, they will 
feel more obliged to follow the rules. This 
practical guide aims to boost the confidence 
of tutors and to assist them in mitigating 
PBL among novice medical students.
This innovative guidebook won a bronze 
medal at the Teaching and Learning 
Congress and Innovation Competition 
(kNovasi) 2020 which was held on 
5-6 February 2020, organised by the 
National University of Malaysia, UKM. 
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Learning Research Ethics 
through MOHRE 
NISHAKANTHI GOPALAN
(Department of Medicine)
NG CHIRK JENN
(Department of Primary Care Medicine)
The recent COVID-19 pandemic has shaken the world. While the front-liners 
battle the pandemic facing public health 
challenges, there is a moral obligation for 
the researchers to provide rapid answers 
to deal with this global emergency. There 
are many ethical considerations involving 
research during a pandemic that are unique 
and require careful examination and 
documentation. The expedited clinical trials 
using unproven investigational drugs with 
the rising mortality rate and the informed 
consent of participants in isolation or 
quarantine, including those suffering the 
illness, are just a few of them. These are 
what an expert with health research ethics 
qualifications will be able to address. 
The Master of Health Research Ethics 
(MOHRE) is a unique programme that 
focuses on building capacity in health 
research ethics, particularly in the Southeast 
Asian region. The programme is taught by a 
team of experienced and transdisciplinary 
faculty members from the University of 
Malaya (UM) and Berman Institute of 
Bioethics, Johns Hopkins University. 
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The Curriculum Development Workshop presented by Dr Sean Tackett from Johns Hopkins University during his recent 
visit to UM and was attended by MOHRE students and faculty members.
Our first hand-picked cohort (2019/2020) awarded with the MOHRE 
scholarship (from left bottom and up): Norizan, Justin (Philippines), 
Naomi, Grazele, Mei Lian, Eliza, Maylene (Philippines), Malini and 
Alex.
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It hopes to groom future leaders in research 
ethics who are competent in handling a broad 
range of ethical concerns in biomedical and 
social science research. The programme is 
designed for individuals who plan to pursue 
careers such as a member or administrator 
of the institutional review boards (IRBs), 
an academician who specializes in research 
ethics or bioethics, a research officer or 
coordinator, and a researcher who works 
with vulnerable populations or leads 
emerging scientific research. 
The one-year full-time coursework 
programme is conducted over two long 
semesters (14 weeks each) and one special 
semester (8 weeks) with most classes 
strategically scheduled on Wednesdays and 
Thursdays to cater to working students. 
During the special semester, the MOHRE 
students will be attached to an IRB, a 
research team or a research organization; 
this will provide them the opportunity to 
experience research ethical issues in the real 
world.
For more information on this programme 
and how to apply, please go to our website 
(https://mohre.um.edu.my/) or drop us an 
email at mohre@um.edu.my. 
*funded by the Fogarty International Center of the 
United States National Institute of Health (NIH)
MOHRE students with the Programme Coordinator, Prof Dr Ng 
Chirk Jenn and Johns Hopkins University counterparts (bottom 
line from left): Joe Ali, Prof Dr Ng Chirk Jenn, Prof Dr Jeremy 
Sugarman and Dr Nishakanthi Gopalan (MOHRE Secretariat). 
Network Meta-analysis: 
The Emerging Trend in 
Evidence Synthesis 
GOH SIEW LI
(Sports Medicine Unit, Faculty of Medicine)
Given that a plethora of treatment options exist for many clinical 
conditions, healthcare practitioners are 
turning to evidence summaries, especially 
meta-analytic reviews, for decision making. 
Synthesizing evidence was conventionally 
performed using pairwise meta-analysis 
technique until about two decades ago 
when network meta-analysis (NMA) was 
introduced. NMA, which is an extension of 
conventional pairwise meta-analysis, is fast 
making its mark in health research (Figure 
1) because it offers several benefits over 
conventional techniques. 
Unlike conventional techniques, 
comparison between multiple treatments 
can be performed coherently in a single 
analysis through NMA (Chandler J et al. 
2019). Hence, NMA is sometimes referred 
to as multiple treatments meta-analysis. For 
example, the comparison of three different 
treatments ABC (i.e. A vs B, B vs C, A vs C) 
which would be conventionally performed 
using three reiterative analyses, can now be 
combined and analyzed simultaneously (as 
long as ABC form a connected network).  
Also, when all treatments are linked, as 
shown in Figure 2, it is possible for NMA to 
derive the estimate between treatment pairs 
that have never been directly evaluated in 
clinical trials. The simplest network where 
ABC are linked is illustrated in Figure 1. 
Although there are no existing studies for 
AB, the comparison between AB can be 
indirectly estimated through AC and BC 
studies. In other words, the results from 
NMA do not only comprise of direct 
estimates, but also indirect estimates,
Figure 1: Indirect estimate in Network meta-analysis. Even in the absence of A-B trials, the A-B can still be compared 
indirectly as both A and B is connected via C. Black solid lines - direct comparison, red broken line – indirect comparison
Dir: Direct; Indir: Indirect. 
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but also indirect estimates. In the eventuality 
of AB trials being found/ conducted, the 
estimates for AB will then become known 
as mixed estimates because, the estimate 
of AB is now comprised of direct as well 
as indirect estimates. A mixed estimate 
is generally more precise than direct or 
indirect estimates alone (e.g. confidence 
interval is narrower). 
The key benefit of NMA is to pool relevant 
evidence and perform comparison for three 
or more treatments simultaneously (even 
in the absence of head-to-head studies). 
However, NMA may also be used to provide 
a concise summary of how each treatment is 
compared to others, permitting researchers 
to identify strength and gaps in the evidence 
base (Figure 3). Additionally, decision 
makers may use NMA to gain information 
on treatment ranking. Treatment ranking, 
which is normally performed under the 
Bayesian framework, may be expressed 
as the probability of each treatment being 
ranked the best. 
However, experts caution against placing 
too much emphasis on the ranking outcome 
for a few reasons; one of which relates to 
the lack of clinical consideration (such 
as treatment risk profile) if the treatment 
ranking were to be interpreted at ‘face value’ 
(Mbuagbaw, L et al 2017). 
Assumptions in NMA are generally similar 
to assumptions in pairwise meta-analysis 
(i.e. studies are sufficiently similar and 
homogeneous with regards to disease 
effect modifiers and study characteristics). 
However, in NMA, the validity of the 
results (especially the indirect evidence) is 
underpinned by additional assumptions. 
These assumptions are assumption of 
consistency between direct and indirect 
estimates (i.e. both estimates should 
agree) and assumption of transitivity (i.e. 
distribution of effect modifiers is similar 
across comparisons). Apart from violation 
of these assumptions, methodological 
flaws and inclusion of poorly conducted/ 
reported clinical trials are among some 
factors that could undermine the quality of 
NMA results. 
It is therefore important to critically 
appraise any meta-analysis work even 
though it is the highest level of evidence. 
Ironically, meta-analysis is in principle an 
observational type of study. It is also easily 
affected by the biases of observational study 
design.
Research Spotlight18
Figure 2: Example of a network plot summarizing 
connectivity of evidence. Treatment groups are 
represented by circles (nodes) while the lines between 
each nodes represents direct comparison. Size of nodes 
and width of lines are proportionate to the number 
of participants and number of studies, respectively. 
(Adapted from Bannuru et al, 2015)
Bridging Translational Cancer 
Research - Current Status, 
Challenges and Future 
Strategies
LOOI MEE LEE
(Department of Biomedical Science)
NUR AISHAH MOHD TAIB
(Department of Surgery)
On 3 March 2020, in conjunction with 
World Cancer Day, the University of 
Malaya Cancer Research Institute (UMCRi) 
organised the “Bridging Translational 
Cancer Research” forum. The forum saw 
participation from UM clinical and pre-
clinical researchers; 47 participants were in 
attendance. The event aimed to provide a 
forum for researchers to share and facilitate 
collaborative research among the UM 
members and hence potentially motivate 
interdisciplinary research grant proposals 
for funding agencies in the future. Prof. 
Dr Nur Aishah Taib, Director of UMCRi 
briefed the participants on UMCRi and 
current restructuring exercise towards UM 
Cancer Institute. She welcome members and 
associate members to participate once the 
restructuring exercise has been completed.
The forum invited renowned researchers 
from UM to share their bench-to-bedside 
Panel of speakers and organising committee. Organising committee members: Dr. Looi Mee Lee, Dr. Kamariah Ibra-
him, Dr. Mohamad Shafiq Azanan, Dr. Jaime Jacqueline Jayapalan.
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Prof. Dr. Vairavan Narayanan presented the roles of surgeon in enhancing 
fundamental clinical research.
research success stories. Prof. Dr Azad 
shared about his lifetime collaboration 
with the Ministry of Health and 
Department of Surgery; the collaboration 
had brought about several high impact 
publications. Assoc. Prof. Dr Fung shared 
a randomised clinical trial on tiger milk 
mushroom funded by the Mahmood 
Merican Grant in collaboration with the 
Oncology, Breast Surgery and Palliative 
Care Unit in the Faculty of Medicine. Prof. 
Dr Bee shared about the development 
of a CAR-T cell programme in UM
Seven medical science researchers from 
various departments and faculties were 
invited to present their fundamental 
research on various topics including 
signalling pathways in cancers, cellular 
models, discovery of biomarkers, detection 
technology, drugs discovery, drug 
development and delivery. The sharing 
session was followed by clinical research 
updates in UM, presented by Assoc. Prof. 
Dr Ho Gwo Fuang. Towards the end of the 
event, Assoc. Prof. Dr Vairavan Narayanan 
led a discussion of potential collaboration 
opportunities and challenges. Concerns 
were raised about the availability of 
funding, conflict of interests, fragmented 
infrastructure, and shortage of qualified and 
research-oriented clinicians. As a solution to 
increase interdisciplinary collaboration and 
synergy between UM clinical and pre-clinical 
cancer researchers, three and two cancer 
projects from the Department of Surgery 
and Department of Oncology respectively 
will be hosted by UMCRi this year to raise 
awareness and networking amongst the 
talent available in the UM community in 
preparation for grant applications in 2021. 
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COMMUNITY ACTIVITIES
A Science Outreach and 
Engagement Story: 
DNA, the Secret of Life
PUAH SUAT MOI
(Department of Biomedical Science)
DNA science is an important field of knowledge because it can provide 
cures for human diseases, improve modern 
medicine, solve environmental challenges 
and offer new agricultural solutions to 
continue feeding the world’s growing 
population. However, in reality, school 
children often find the topics of DNA dry 
and, sometimes, tricky to understand. 
As part of UMCares’ community 
engagement project, two workshops on 
DNA science have been organized for 
secondary school students in the science 
stream. The primary aim of the workshops 
was to cultivate interest on learning DNA 
science in secondary school students 
with lively and engaging activities. The 
workshop is a collaborative effort with the 
Kelab Sahabat UM Network to reach out 
to nearby secondary schools in Petaling 
Jaya via a “Meet and Greet” session. With 
adherence to the core value of UMCares – 
“signifying the university’s commitment to
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Secondary students from SMK(P) Sri Aman showed their experiment output with excitement and satisfaction - visible 
clumps of DNA.
sustainability and community engagement”, 
household items such as salt and detergent 
were used as the workshop materials to 
enable easy access for the students to repeat 
the experiments at home or schools.
In early February and March of 2020, we 
conducted the workshops at SMK(P) Sri 
Aman and SMK Lembah Subang, with the 
involvement of Biomedical Science Year 1 
and Year 2 students as facilitators. The target 
participants were upper secondary students 
who had learnt about DNA in school. The 
workshop started with a quick ice-breaking 
session and a lively introduction to DNA 
science, followed by hands-on DNA 
extraction from their own cheek cells, as 
well as different mashed fruits including 
banana, kiwi, orange and papaya under 
close facilitation and guidance. Before the 
end of the workshops, an interactive quiz 
and survey was conducted to gauge their 
interest level in DNA science.
Out of 76 post-workshop survey responses, 
92% of the secondary school students 
agreed that their interest in DNA learning 
was strongly stimulated after the workshop 
compared to before the workshop (64%). 
On top of that, more than 90% of the 
students could understand DNA topics 
to explain the abstract concepts of DNA 
science better through hands-on activities 
during the workshops, as compared to 
traditional classroom teaching. The hands-
on experience and practical learning in 
this outreach programme gave positive 
responses and we are looking forward to 
more exciting upcoming projects whereby 
students will be exposed to DNA techniques 
and their uses in real-life scenarios.  
Household materials (salt, detergent, and alcohol) and 
fruits for DNA extraction hands-on experiment during the 
workshop: DNA, The Secret of Life. 
An internal workshop training for paper-based DNA fingerprinting module.
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ACHIEVEMENTS
AWARDS
Achievements23
DR. WONG KAH HUI, DR. FOONG CHAN CHOONG, DR. AMIRAH AMIR
• Bronze Medal in Teaching and Learning Congress and Competition (kNovasi) 2020 
PROFESSOR DATO’ DR. TAN CHONG TIN
• Tan Kah Kee Award 2019
DATUK PROFESSOR DR. LOOI LAI MENG
• Appointment to the Medical Research Council (UK) Applied Global Health Research 
Board
DR. JAIME JACQUELINE JAYAPALAN
• Outstanding Women in Health & Medical Sciences, Venus International Foundation, 
2020
DR. JASMINE LIM
• First place in Royal Academy of Engineering’s Leaders in Innovation Fellowships 
(LIF) final pitch session 2019/2020
MS. LYE AN JIE, MDM CHE RAFIDAH AZIZ, DR. FOONG CHAN CHOONG, PROFESSOR 
DR. JAMUNA VADIVELU
• Gold Medal in Teaching and Learning Congress and Competition (kNovasi) 2020
DR WONG KAH HUI, MS. LEW SZE YUEN
• Gold Award in the Malaysian Technology Exposition (MTE) 2020 - The 19th 
International Expo on Inventions & Innovations (Category: Invention & Innovation 
Awards) 
UPCOMING EVENTS
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HERO
(HEALTH RESEARCH ONLINE COURSE)
COURSE OFFER :  
 
CLASS 1 :  6  JAN  2020 -  22  FEB  2020 
CLASS 2 :  1 6  MAR 2020 -  26  APR  2020 
CLASS 3 :  1  JUN  2020 -  5  JUL  2020 
CLASS 4 :  1  SEPT  2020 -  1 1  OCT  2020 
 
 
INTRODUCTION TO RESEARCH 
FOR HEALTHCARE 
PROFESSIONALS 
 
DEF IN ING A RESEARCH QUEST ION.  
L I TERATURE SEARCH.     
QUANT ITAT IVE METHODS.   
QUAL ITAT IVE METHODS.     
WR IT ING RESEARCH PROPOSAL.   
ETH ICS AND FUNDING.
A 6-WEEK E-LEARNING COURSE 
BY FACULTY OF MEDICINE,  UM 
To enrol ,  contact:  
tongwenting@um.edu.my
More information
FREE*
*for FOM UM lecturers and clinical masters candidates. 
For others, participation fee is RM200
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READ TIPS
COMMUNITY HEALTH NURSING 
SECOND EDITION
Author: Chong Mei Chan  
Publisher: Oxford Fajar
ISBN: 978-983-47-2860-1
Community Health Nursing is a localized 
textbook for nursing students pursuing a 
Diploma in Nursing in Malaysia. This book was 
published as there was a great need for a localized 
textbook on Community Health Nursing as this 
subject is very much country-specific based 
on current needs and the health climate in the 
country. Community nursing practices specific 
to Malaysia are covered in this book. 
The text covers a broad range of topics; divided into family health care, social issues, and 
epidemiology; and this is well structured to aid students in their learning process and in 
the understanding of local Community Health Nursing. This textbook will be useful in 
laying a strong foundation for nursing students. It can also be a useful reference tool for 
allied health sciences students and practising nurses. The textbook is supplemented by 
an on-line resource which will provide students with resource material (Students’ Re-
source), including a question bank with answers as well as Instructor’s Resource materi-
al which includes PowerPoint teaching presentations, solution manuals and instructor’s 
manuals.
AUTISM IN SHORT: A HANDBOOK FOR 
PARENTS
Author: Subhashini A/P Jayanath
Publisher: Gerakbudaya Enterprise
ISBN: 978-967-0311-24-1 
This book is a brief guide on autism spectrum 
disorder for parents of young children.
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RESEARCH OFFICE
DEAN’S OFFICE
LEVEL 3. BLOCK I, FACULTY OF MEDICINE
UNIVERSITI MALAYA
50603 KUALA LUMPUR
TEL: 03-7967 7515
Email: resfom@um.edu.my
RO Website: https://resfom.um.edu.my
FOM Website: https://medicine.um.edu.my
Research Office - FOM UM
@fom_um
@fom_research_um
